Trillium Therapeutics Inc. (TRIL) Social Stream
Warning: This security is no longer trading. On November 17, 2021, Pfizer Inc. (NYSE: PFE) announced the successful completion of its acquisition of Trillium Therapeutics, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.
Featured Post From StockTwits About TRIL
$VERB lol just deleting some old pictures. This is a good 1 of $FTSV & $TRIL . tril was 1500% bank and ftsv was pretty good. Ftsv no longer trades as gild bought it out at some great premium 96 bucks. I owned since 5 but 99% of my size at 30-40. U see ftsv would be down 3,4,5 bucks some days. But know what u own and u post silly messages like this instead of selling. I am still laughing at this postvaluationgman, published August 5, 2021